A Way To Screen for Ovarian Cancer?

Looking at the rate of change in a blood test may be a good way to screen healthy women for ovarian cancer, a new study suggests. This form of cancer usually is diagnosed late, when it is hard to cure. The new study included a test for the protein CA-125. Blood levels are high in many women with ovarian cancer. But this protein can be high for other reasons, too. More than 3,200 older women were tested for CA-125. Researchers calculated each woman’s risk based on her CA-125 level and how it changed over time. Women at low risk were tested each year. Medium-risk women got tests every three months. The study lasted nine years. In this time, 85 women with the highest risk received ultrasound tests to look for signs of cancer. Eight of them were referred for surgery. The surgery found three invasive cancers, all in early stages. Two women had “borderline” tumors.

Content restricted. Requires subscription

FDA: Rotavirus Vaccine OK for Use

Doctors can resume giving children either of the two vaccines available for rotavirus, U.S. regulators say. The announcement came nearly two months after doctors were asked to suspend use of one of the vaccines, Rotarix. Bits of DNA from a pig virus had been found in the vaccine. Rotarix is made by GlaxoSmithKline. The FDA said the vaccine was safe and was being suspended as a precaution. The pig virus, porcine circovirus 1, is not known to cause illness in people. In early May, the FDA said the other vaccine, RotaTeq, also contained pig virus DNA. RotaTeq is made by Merck. After completing its investigation, the FDA dropped the suspension of Rotarix. The agency said both vaccines are safe and doctors can use either one. HealthDay News wrote about the announcement May 14.

Content restricted. Requires subscription